IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A TWO-YEAR FOLLOW-UP STUDYM. S. Naumtseva, Yu. V. Muravyev, А. А. Новиков et al.|Rheumatology Science and Practice|2017Cited by 9